share_log

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 5:00 p.m. (ET)

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 5:00 p.m. (ET)

曼恩凯德生物医疗 | 8-K:MANNKIND CORPORATION公布2023年第四季度和全年财务业绩:提供临床开发更新电话会议,将于今天下午 5:00(美国东部时间)开始
SEC announcement ·  02/27 16:07
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息